STOCK TITAN

vTv Therapeutics: Samsara proposes $1.32M share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

vTv Therapeutics Inc. (VTVT) is the issuer in a notice listing a proposed sale by shareholder Samsara BioCapital, L.P. of 61,287 common shares, with an aggregate market value of $1,315,831.89 and an approximate sale date of November 12, 2026. Merrill Lynch is listed as broker. The notice lists 4,011,465 common shares outstanding.

Proposed sale shares 61,287 common shares Samsara BioCapital, L.P.; approximate sale date November 12, 2026.
Aggregate market value $1,315,831.89 For the common shares listed for proposed sale.
Common shares outstanding 4,011,465 shares Issuer count listed in the notice.
Open-market acquisition 1,000 shares Acquired November 18, 2021.
Private-placement acquisition 4,055 shares Acquired February 27, 2024.
Warrant exercise 56,232 shares Acquired September 9, 2026, by net exercise.
Aggregate Market Value financial
"Aggregate Market Value of securities to be sold"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Private Placement financial
"Nature of acquisition: Private Placement"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
Warrant Exercise financial
"Nature of acquisition: Warrant Exercise"
A warrant exercise is when the holder of a warrant pays a preset price to convert that warrant into actual company shares. Think of it like using a coupon to buy a product at a locked-in price; if the market price is higher, the buyer gains immediate value. For investors it matters because exercising brings cash into the company but also increases the total number of shares, which can reduce each existing shareholder’s ownership percentage and affect the stock price.
Net Exercise financial
"Nature of Payment: Net Exercise"
A net exercise is a way to convert stock options into shares without paying cash up front: instead of handing over money to buy the optioned shares, the holder receives only the number of shares equal to the option’s value after the company withholds a portion of shares to cover the exercise price and taxes. It matters to investors because it changes how many new shares are issued, affects dilution of existing shareholders, and alters company cash flow compared with a cash exercise.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VTVT shares does Samsara BioCapital plan to sell?

Samsara BioCapital, L.P. reported a proposed sale of 61,287 common shares, with an aggregate market value of $1,315,831.89 and an approximate sale date of November 12, 2026. Merrill Lynch is listed as the broker.

How did Samsara BioCapital acquire the VTVT shares listed for sale?

The listed acquisitions were 1,000 shares in an open-market transaction on November 18, 2021; 4,055 shares in a private placement on February 27, 2024; and 56,232 shares through a warrant exercise on September 9, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading